Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year double-digit growth; how rare diseases was the foundation of Sanofi Genzyme´s business and remains a key part of their DNA; and how a focus on patient centricity remains at the core of their success.
Switzerland was one of the latest Sanofi Genzyme European affiliates to be developed, being active since 2003. Can you give us an overall overview of the affiliate today?
"We are the rare disease pioneer. This is the foundation of Sanofi Genzyme´s success."
